Keytruda®, Pembrolizumab, is an innovative, anti cancer monoclonal antibody  immunotherapy drug.

The drug blocks the link between the cancer cell PD-L1 ligand, to a patient’s immune system PD-1 receptor , helping the immune system kill the cancer cells.

To read more:


To check if our service suits your case
We need to talk

Improve therapeutic outcomes, prolong life and quality of life, are our main business.
We support access to and expand cancer treatments beyond the standard of care, with the most advanced and innovative treatment options in the world, personally matching the individual cancer patient’s medical condition and with the support of top tier oncologists.

Article categories

קטגוריות המאמרים

Popular topics